Clinical trial for Focal Epilepsy
Official title Spatial Scene Recognition Memory in Epilepsy Surgery
ClinicalTrials.gov ID: NCT07580183
What this study is testing
- What it's testing
- The study looks at how memory for places works in people with temporal lobe epilepsy and how this might help predict memory problems after surgery.
- Who it's for
- It is looking for adults who have temporal lobe epilepsy and are planning or have had epilepsy surgery.
- What's involved
- Participants will take part in a virtual tour test that asks them to recognize and recall places, and some will have brain activity recorded while they do the test.
- Time commitment
- The study lasts about a few hours for each visit, with a single visit for the virtual tour and additional visits for brain recordings if needed.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55. Healthy volunteers may be eligible.
You may be able to join if
- Age 18 years or older
- For Aims I and III: Diagnosis of focal epilepsy or temporal lobe lesion; patients undergoing evaluation for or having undergone epilepsy surgery
- For Aim II: Healthy adult participants
- Full-Scale IQ ≥ 70
- English proficiency sufficient to understand and complete the task
You likely can't join if
- Full-Scale IQ \< 70
- Inability to provide informed consent
- For Aim III: Age \> 55 years
- For Aim II: History of neurological or psychiatric disorder (as applicable per study protocol)
See the full eligibility criteria
- Age 18 years or older
- For Aims I and III: Diagnosis of focal epilepsy or temporal lobe lesion; patients undergoing evaluation for or having undergone epilepsy surgery
- For Aim II: Healthy adult participants
- Full-Scale IQ ≥ 70
- English proficiency sufficient to understand and complete the task
- For Aim I: Enrolled in or eligible for Emory University epilepsy surgery research registry
- For Aim III: Undergoing clinically indicated stereoelectroencephalography (SEEG) at UC Davis Medical Center
- Able to provide informed consent (or for Aim I retrospective component, prior consent in Emory registry)
- Full-Scale IQ \< 70
- Inability to provide informed consent
- For Aim III: Age \> 55 years
- For Aim II: History of neurological or psychiatric disorder (as applicable per study protocol)
The study team makes the final eligibility decision.
Where it is enrolling
- Sacramento, California, United States
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Sacramento, California, United States; Atlanta, Georgia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.